Inhibition of demethylases by GSK-J1/J4

Nature

Volumn 514, Issue 7520, 2014, Pages E1-E2

  Heinemann, Bo ^a   Nielsen, Jesper Morten ^a   Hudlebusch, Heidi Rye ^a   Lees, Michael J ^b   Larsen, Dorthe Vang ^a   Boesen, Thomas ^a   Labelle, Marc ^a   Gerlach, Lars Ole ^a   Birk, Peter ^a   Helin, Kristian ^b,c  

^a EpiTherapeutics Aps ^*  (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; GSK J1; GSK J2; HISTONE DEMETHYLASE; UNCLASSIFIED DRUG;

BIOASSAY; CATALYST; ENZYME ACTIVITY; INHIBITION;

ARTICLE; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; COMPETITIVE INHIBITION; DEMETHYLATION; IC50; PRIORITY JOURNAL; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; IMMUNOLOGY; MACROPHAGE; NOTE;

ANIMALS; ENZYME INHIBITORS; HUMANS; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; MACROPHAGES;

EID: 84908029332     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature13688     Document Type: Article

References (6)

1. Kruidenier, L. et al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature 488, 404-408 (2012).
2. Helin, K. & Dhanak, D. Chromatin proteins and modifications as drug targets. Nature 502, 480-488 (2013).
3. Kooistra, S. M. & Helin, K. Molecular mechanisms and potential functions of histone demethylases. Nature Rev. Mol. Cell Biol. 13, 297-311 (2012).
4. Arrowsmith, C.H., Bountra, C., Fish, P.V., Lee, K. & Schapira, M. Epigenetic protein families: a new frontier for drug discovery. Nature Rev. Drug Discov. 11, 384-400 (2012).
5. Greer, E. L. & Shi, Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nature Rev. Genet. 13, 343-357 (2012).
6. Højfeldt, J. W., Agger, K. & Helin, K. Histone lysine demethylases as targets for anticancer therapy. Nature Rev. Drug Discov. 12, 917-930 (2013).